Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,109 | -4,112 | -8,949 | -1,485 | -1,611 |
| Other Working Capital | 166 | -150 | 133 | -168 | -321 |
| Other Operating Activity | 252 | 138 | -740 | -1,914 | 703 |
| Operating Cash Flow | $-2,691 | $-4,125 | $-9,556 | $-3,567 | $-1,229 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,045 |
| Common Stock Issued | 4,700 | 4,424 | 5,044 | 4,430 | 6,859 |
| Financing Cash Flow | $4,700 | $4,424 | $5,044 | $4,430 | $7,904 |
| Beginning Cash Position | 3,325 | 3,027 | 7,538 | 6,675 | N/A |
| End Cash Position | 5,334 | 3,325 | 3,027 | 7,538 | 6,675 |
| Net Cash Flow | $2,009 | $299 | $-4,512 | $863 | $6,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,691 | -4,125 | -9,556 | -3,567 | -1,229 |
| Free Cash Flow | -2,691 | -4,125 | -9,556 | -3,567 | -1,229 |